Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline in pediatric anxiety disorders
NCT04221997Phase 4Recruiting
- Sponsor
- University of Cincinnati
- Start
- Nov 2019
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sertraline in generalized anxiety disorder (GAD), Social Anxiety Disorder (SAD), separation anxiety disorder (SAD), sponsored by University of Cincinnati. Started Nov 2019; status: recruiting.
02
Drugs
sertraline
03
Conditions
generalized anxiety disorder (GAD)Social Anxiety Disorder (SAD)separation anxiety disorder (SAD)
Beyond the preview
Go deeper on NCT04221997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04221997.